There are more than 1,300 clinical trials in hepatology, either ongoing or planned, in Asia-Pacific. This represents about 60% of all ongoing and planned hepatology trials globally. Liver diseases are highly prevalent in the Asia-Pacific region. The region hosts some…
First Covid-19 vaccine candidate trial begins in Australia
The first clinical trials of a Covid-19 vaccine developed in Australia have commenced at Royal Adelaide Hospital’s PARC Clinical Research facility. Named COVAX-19, the targeted vaccine has been developed by company Vaxine and researchers at Flinders University. During the first…
Sanofi and Regeneron’s Kevzara fails in Phase III Covid-19 trial
Sanofi and Regeneron Pharmaceuticals have reported that a Phase III clinical trial of rheumatoid arthritis drug Kevzara (sarilumab) failed to meet its primary and key secondary endpoints in Covid-19 patients who required mechanical ventilation in the US. The study compared…
Abivax doses first patient in Phase II/III Covid-19 clinical trial
French biotechnology company Abivax has dosed the first patient in its Phase II/III study of ABX464 in Covid-19 patients at the University Hospital Center in Nice, France. This randomised, double-blind, placebo-controlled miR-AGE study investigates the effect of early treatment in…
Durham-based IQVIA to launch massive clinical research site in Canada
RESEARCH TRIANGLE PARK — IQVIA has secured a deal with LMC Manna Research to launch what it says is the largest clinical research site in Canada. That adds to its network of more than 980 Prime and Partner clinical sites…
13 COVID-19 Vaccines Are in Human Clinical Trials – What Are They?
The world is now several months into the COVID-19 global pandemic caused by the SARS-CoV-2 virus. As lockdown restrictions slowly begin to lift in certain regions, the pursuit for a safe and effective vaccine against the virus continues – and…
Ridgeback Biotherapeutics initiates Phase II Covid-19 trials
US-based biotechnology company Ridgeback Biopharmaceuticals has initiated two Phase II clinical trials of EIDD-2801 for the treatment of Covid-19. EIDD-2801 was invented by Drug Innovations at Emory (DRIVE) researchers at Emory University. Ridgeback licensed the programme in March this year.…
Oxford Covid-19 vaccine trials start in South Africa and Brazil
Researchers in South Africa and Brazil have initiated clinical trials to assess a Covid-19 vaccine candidate, ChAdOx1 nCoV-19 (AZD1222), developed by the University of Oxford and licensed to AstraZeneca. Sponsored by Lemann Foundation, the trial in Brazil will assess the…
FibroGen enrols first patient in pamrevlumab’s Covid-19 trial in US
FibroGen has started enrolment for a Phase II clinical trial of pamrevlumab for the treatment of patients hospitalised due to Covid-19 in the US. Pamrevlumab is an antibody designed to block the activity of connective tissue growth factor (CTGF), which…
Few employees want to return to office full-time when lockdowns are eased: Poll
Remote working or working from home has become the new norm during the COVID-19 times which call for maintaining physical distancing and complying with lockdown measures to curb disease spread. Working from home has multiple benefits such as eliminating the…
